Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedThe site footer revision changed from v3.8.0 to v3.8.1. The study record history remains unchanged.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov footer displays a newer site software revision, changing from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check28 days agoChange DetectedA notice was added announcing NIH website transition updates and saying that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.8%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedA new site revision entry v3.7.0 was added. The previous revision v3.6.6 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.